Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Bonderman

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Panminerva Medica|February 15, 2023
Cardiac amyloidosis: a significant blind spot of the H2FPEF scoreFranz Duca, Rene Rettl, Christina Binder, et al.
ESC Heart Failure|January 20, 2025
Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIREMarcin Ufnal, Kathleen Connolly, Marcus Millegard, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyJ Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
European Heart Journal. Cardiovascular Imaging|November 17, 2021
Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathyRené Rettl, Christopher Mann, Franz Duca, et al.
Heart (British Cardiac Society)|October 30, 2021
Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosisLore Schrutka, Philip Anner, Asan Agibetov, et al.
Annals of the Rheumatic Diseases|October 25, 2017
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohortCarina Mihai, Milos Antic, Rucsandra Dobrota, et al.
Journal of Personalized Medicine|December 24, 2021
Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance ImagingAsan Agibetov, Andreas Kammerlander, Franz Duca, et al.
Journal of Clinical Medicine|February 25, 2023
Cardiopulmonary Long-Term Sequelae in Patients after Severe COVID-19 DiseaseJulia Hanne Niebauer, Christina Binder-Rodriguez, Ahmet Iscel, et al.
European Heart Journal|August 1, 2022
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trialTheresa Marie Dachs, Franz Duca, René Rettl, et al.
JACC. Heart Failure|May 3, 2023
Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIAJaved Butler, Yinggan Zheng, Muhammad Shahzeb Khan, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Panminerva Medica|February 15, 2023
Cardiac amyloidosis: a significant blind spot of the H2FPEF scoreFranz Duca, Rene Rettl, Christina Binder, et al.
ESC Heart Failure|January 20, 2025
Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIREMarcin Ufnal, Kathleen Connolly, Marcus Millegard, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyJ Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
European Heart Journal. Cardiovascular Imaging|November 17, 2021
Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathyRené Rettl, Christopher Mann, Franz Duca, et al.
Heart (British Cardiac Society)|October 30, 2021
Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosisLore Schrutka, Philip Anner, Asan Agibetov, et al.
Annals of the Rheumatic Diseases|October 25, 2017
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohortCarina Mihai, Milos Antic, Rucsandra Dobrota, et al.
Journal of Personalized Medicine|December 24, 2021
Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance ImagingAsan Agibetov, Andreas Kammerlander, Franz Duca, et al.
Journal of Clinical Medicine|February 25, 2023
Cardiopulmonary Long-Term Sequelae in Patients after Severe COVID-19 DiseaseJulia Hanne Niebauer, Christina Binder-Rodriguez, Ahmet Iscel, et al.
European Heart Journal|August 1, 2022
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trialTheresa Marie Dachs, Franz Duca, René Rettl, et al.
JACC. Heart Failure|May 3, 2023
Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIAJaved Butler, Yinggan Zheng, Muhammad Shahzeb Khan, et al.
Pageof 13